Last update:

Oncology & Cancer news

Oncology & Cancer

Harnessing natural killer T cells to advance cancer immunotherapy for solid tumors

In the fight against cancer, chimeric antigen receptor T cell (CAR-T) therapy has achieved notable success in treating blood cancers. However, it has been largely ineffective against solid tumors.

Oncology & Cancer

AI model shows potential for identifying sex-specific risks associated with brain tumors

For years, cancer researchers have noticed that more men than women get a lethal form of brain cancer called glioblastoma. They've also found that these tumors are often more aggressive in men. But pinpointing the characteristics ...

Oncology & Cancer

Study explores novel therapeutic treatment for glioblastoma

Glioblastoma (GBM) is the most lethal brain tumor, with a median survival rate of merely 12-16 months after diagnosis. Despite surgical, radiation and chemotherapy treatments, the two-year survival rate for GBM patients is ...

Oncology & Cancer

Study unveils the role of gamma-delta T cells in cancer immunology

A new study published in Cell Reports Medicine reveals critical insights into the role of gamma-delta T cells across 33 cancer types, shedding light on their potential as clinical biomarkers and therapeutic targets in cancer ...

Oncology & Cancer

Colonoscopies among the young are on the rise

Colon cancers are increasing among younger Americans, so much so that experts advised in 2021 that colonoscopy screening begins at the age of 45, not 50 as had been previously recommended.

Oncology & Cancer

Uncovering why some cells become resistant to anti-cancer therapies

A research team led by Northwestern University and the University of Pennsylvania scientists has created a new synthetic biology approach, a "QR code for cancer cells," to follow tumor cells over time, finding there are meaningful ...

Oncology & Cancer

Detecting breast cancer earlier with 3D X-rays

In 2020, breast cancer was the most commonly diagnosed form of cancer worldwide, with more than 2 million cases. In women, it accounts for about a quarter of all cancer cases and is responsible for 15.5% of cancer-related ...